Goldman Sachs’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48.1M | Buy |
|
|||||
|
2025
Q1 | $29.5M | Sell |
|
|||||
|
2024
Q4 | $54.3M | Buy |
|
|||||
|
2024
Q3 | $46.8M | Sell |
|
|||||
|
2024
Q2 | $51.1M | Buy |
|
|||||
|
2024
Q1 | $13.8M | Sell |
|
|||||
|
2023
Q4 | $16.4M | Buy |
|
|||||
|
2023
Q3 | $14.9M | Sell |
|
|||||
|
2023
Q2 | $16.7M | Buy |
|
|||||
|
2023
Q1 | $14.7M | Sell |
|
|||||
|
2022
Q4 | $19.6M | Buy |
|
|||||
|
2022
Q3 | $10.4M | Buy |
|
|||||
|
2022
Q2 | $6.29M | Sell |
|
|||||
|
2022
Q1 | $8.01M | Buy |
|
|||||
|
2021
Q4 | $6.18M | Buy |
|
|||||
|
2021
Q3 | $7.29M | Buy |
|
|||||
|
2021
Q2 | $4.83M | Sell |
|
|||||
|
2021
Q1 | $12.9M | Sell |
|
|||||
|
2020
Q4 | $14.3M | Sell |
|
|||||
|
2020
Q3 | $12.6M | Sell |
|
|||||
|
2020
Q2 | $13.5M | Sell |
|
|||||
|
2020
Q1 | $81M | Buy |
|
|||||
|
2019
Q4 | $39.6M | Buy |
|
|||||
|
2019
Q3 | $40.2M | Buy |
|
|||||
|
2019
Q2 | $35.2M | Buy |
|
|||||
|
2019
Q1 | $18.9M | Buy |
|
|||||
|
2018
Q4 | $18M | Buy |
|
|||||
|
2018
Q3 | $16.7M | Sell |
|
|||||
|
2018
Q2 | $34.8M | Buy |
|
|||||
|
2018
Q1 | $12.1M | Buy |
|
|||||
|
2017
Q4 | $9.21M | Buy |
|
|||||
|
2017
Q3 | $5.75M | Buy |
|
|||||
|
2017
Q2 | $2.07M | Sell |
|
|||||
|
2017
Q1 | $5.62M | Buy |
|
|||||
|
2016
Q4 | $5.44M | Sell |
|
|||||
|
2016
Q3 | $8.07M | Sell |
|
|||||
|
2016
Q2 | $6.74M | Buy |
|
|||||
|
2016
Q1 | $8.09M | Buy |
|
|||||
|
2015
Q4 | $638K | Sell |
|
|||||
|
2015
Q3 | $1.76M | Buy |
|
|||||
|
2015
Q2 | $1.29M | Sell |
|
|||||
|
2015
Q1 | $7.21M | Buy |
|
|||||
|
2014
Q4 | $457K | Sell |
|
|||||
|
2014
Q3 | $851K | Sell |
|
|||||
|
2014
Q2 | $3.53M | Buy |
|
|||||
|
2014
Q1 | $527K | Sell |
|
|||||
|
2013
Q4 | $4.44M | Buy |
|
|||||
|
2013
Q3 | $3.33M | Buy |
|
|||||
|
2013
Q2 | $1.12M | Buy |
|